Qin Xiusen, Su Mingli, Guo Huili, Peng Binying, Luo Rui, Ye Junwen, Wang Hui
Department of General Surgery The Sixth Affiliated Hospital Sun Yat-sen University Guangzhou China.
Guangdong Institute of Gastroenterology Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases Biomedical Innovation Center The Sixth Affiliated Hospital Sun Yat-sen University Guangzhou China.
Smart Med. 2023 Jul 13;2(3):e20230013. doi: 10.1002/SMMD.20230013. eCollection 2023 Aug.
Peritoneal surface malignancies (PSM) can originate from tumors in many organs and are highly malignant, and difficult to diagnose and cure, posing a serious threat to the survival of patients. Although the diagnosis and treatment of PSM have made significant progress in the past two decades, numerous challenges remain. Recently, functionalized biomaterials have shown promise for PSM diagnosis and treatment. Hence, we review the progress of functionalized biomaterials for the diagnosis and treatment of PSM. We first introduce the classification and pathogenesis of PSM. We then discuss the applications of functionalized biomaterials for the diagnosis and treatment of PSM. In particular, we focus on functionalized biomaterials as drug carriers for the treatment of PSM, including chemotherapy, immunotherapy, targeted therapy, combination therapy, and other therapies. Finally, we summarized the current challenges and provided a perspective on the diagnosis and treatment of PSM.
腹膜表面恶性肿瘤(PSM)可起源于多个器官的肿瘤,具有高度恶性,诊断和治疗困难,对患者的生存构成严重威胁。尽管在过去二十年中PSM的诊断和治疗取得了重大进展,但仍存在许多挑战。最近,功能化生物材料在PSM的诊断和治疗方面显示出前景。因此,我们综述了功能化生物材料在PSM诊断和治疗方面的进展。我们首先介绍PSM的分类和发病机制。然后我们讨论功能化生物材料在PSM诊断和治疗中的应用。特别是,我们重点关注功能化生物材料作为治疗PSM的药物载体,包括化疗、免疫疗法、靶向治疗、联合治疗和其他疗法。最后,我们总结了当前的挑战,并对PSM的诊断和治疗提供了展望。